2026-06-14T03:42:20Zhttps://repisalud.isciii.es/rest/oai/requestoai:repisalud.isciii.es:20.500.12105/252772024-10-23T13:07:22Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16958
Repisalud
author
García-Heredia, José Manuel
author
Carnero, Amancio
2024-10-23T13:07:22Z
2024-10-23T13:07:22Z
2020-07-15
10.3390/cells9071693
2073-4409
Cells
http://hdl.handle.net/10668/15954
32679735
https://hdl.handle.net/20.500.12105/25277
Cancer stem cells (CSC) are associated with the mechanisms of chemoresistance to different cytotoxic drugs or radiotherapy, as well as with tumor relapse and a poor prognosis. Various studies have shown that mitochondria play a central role in these processes because of the ability of this organelle to modify cell metabolism, allowing survival and avoiding apoptosis clearance of cancer cells. Thus, the whole mitochondrial cycle, from its biogenesis to its death, either by mitophagy or by apoptosis, can be targeted by different drugs to reduce mitochondrial fitness, allowing for a restored or increased sensitivity to chemotherapeutic drugs. Once mitochondrial misbalance is induced by a specific drug in any of the processes of mitochondrial metabolism, two elements are commonly boosted: an increment in reactive nitrogen/oxygen species and, subsequently, activation of the intrinsic apoptotic pathway.
eng
Cancer stem cells
Drug resistance
Metabolic plasticity
Mitochondria
Role of Mitochondria in Cancer Stem Cell Resistance.
research article